Harvard Bioscience Investor Relations Material
Latest events
Q3 2024
Harvard Bioscience
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Harvard Bioscience Inc
Access all reports
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. It operates in two segments, Lab Products Group and Specialty Life Science Group. The Specialty Life Science Group segment manufactures and sells specialized life science research products to pharmaceutical companies and academic institutions. This segment offers large protein electrophysiological instrumentation, including voltage or current-clamp amplifiers; multi-photon excitation instruments used in optical imaging; scientific cameras and software; advanced microscopy; cell charting systems that detect morphological changes in cells; mass spectrometers; respirometers and other physiological measurement equipment; syringe pumps; microinjectors for small animals; oxygenators for tissue engineering applications used for cell culture work on a laboratory benchtop.
Key slides for Harvard Bioscience Inc
Q2 2024
Harvard Bioscience Inc
Q2 2024
Harvard Bioscience Inc
Latest articles
Master of Tickets: Breaking Down Live Nation Entertainment
Since merging in 2010, Ticketmaster and Live Nation have built an expansive ecosystem that dominates global live entertainment.
6 Dec 2024
Peter Beck: The Innovator at Rocket Lab
Peter Beck, born and raised in New Zealand, is one of the key individuals in the aerospace industry as the founder and CEO of Rocket Lab.
6 Dec 2024
Prada: The Story of an Icon
Prada's journey from a small Milan boutique to a global luxury empire, led by Miuccia's innovation and creativity.
5 Dec 2024
Ticker symbol
HBIO
Country
🇺🇸 United States